Utilizing MiSeq Sequencing to Detect Circulating microRNAs in Plasma for Improved Lung Cancer Diagnosis

Non-small cell lung cancer (NSCLC) is a major contributor to cancer-related deaths, but early detection can reduce mortality. NSCLC comprises mainly adenocarcinoma (AC) and squamous cell carcinoma (SCC). Circulating microRNAs (miRNAs) in plasma have emerged as promising biomarkers for NSCLC. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Xinyan, Tsou, Jen-Hui, Stass, Sanford A., Jiang, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299334/
https://www.ncbi.nlm.nih.gov/pubmed/37373422
http://dx.doi.org/10.3390/ijms241210277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299334/
https://www.ncbi.nlm.nih.gov/pubmed/37373422
http://dx.doi.org/10.3390/ijms241210277

Ejemplares similares